Production targets

Production targets

Liguid target for F18 production

ion source

ion source

internal H- ion source for PET cyclotron

AIMA & trends in Nuclear Medicine

 

From its early years, Nuclear Medicine is a powerful diagnostics tool using scintigraphy with single photons (SPECT). This activity is mature and now slowly decreasing while the new imaging modality based on positron emitters isotopes (PET) is very promising, but still in its infancy and fast growing.

- For SPECT the most widely used radioisotope is Technetium-99m (Tc99m). Because of foreseen world shortages of reactors route ( most of them will stop in 2015-2016) the IAEA and OCDE experts have recommended to explore alternative production methods based on accelerators. Therefore dedicated high intensity cyclotrons could be the working horses of these new routes.

- The PET activity is in full swing worldwide, with 80% of the PET scans exams in oncology and 20% in neurology.

 

Today about 80% of the PET exams use Fluorine-18 (F18) based radiotracers. On-going research trials throughout the world are investigating new radiopharmaceuticals for PET for both diagnosis and therapy and it is anticipated that the market growth will be multiplied by 5 in the near future.

The main disadvantage of PET radiapharmaceutical is their short half-life (e.g. 110 min for F18), which results in complex logistics problems (outdoors production, transport).

For a Nuclear Medicine department which plans to use isotopes with an even shorter half-life, the solution is a dedicated mini-cyclotron, easy to installed, close to the patients. 

 

AIMA experience

The AIMA PN PET cyclotron

 

Before the creation of AIMA Developpement, our experts have designed realized and commissionned from A to Z a 15 MeV/80 μA dual beam cyclotron between 2002 and 2005. The rights of this machine have been sold to the industry.

 

Up to now, AIMA has developped many skills in accelerator design and is presently working on 2 innovative machines that offer response to the present and future needs in isotopes of nuclear medicine. 

Expertise

Expertise

Innovative cyclotron design is the core expertise of AIMA: - Dedicated software tools - Construction of specific subsystems - Test benches for ion sources and injection systems

Particle Therapy

Particle Therapy

AIMA has a long experience designing particle therapy equipments. In the recent years AIMA proposed the S2C2™, the brand new IBA superconducting synchrocyclotron for protontherapy.

Nuclear Medicine

Nuclear Medicine

Our experts have fully developed and commissioned a PET cyclotron that has been industrialized & commercialized for FdG radioisotope production. AIMA is now involved with several designs of PET & SPECT production machines.

High power

High power

AIMA proposes a single stage very high power accelerator concept (patented) dedicated to fundamental physics and Industrial applications: Nuclear waste transmutation, clean and safe energy production.

Please come for a visit!

ADDRESS       Laboratoire du Cyclotron

                          227, avenue de la Lanterne

Zip Code          06200 

City                   Nice

Country            France

Phone              +33 (0)4 93 83 58 41

contact@aima.fr

Any question?

A job opportunity ?

Please contact us